AB — AB Science SA Cashflow Statement
0.000.00%
Last trade - 00:00- €77.84m
- €88.40m
- €1.07m
Annual cashflow statement for AB Science SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | — | — | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15 | -14.5 | -13.6 | -12 | -7.83 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.207 | 1.07 | -1.03 | -2.73 | 1.64 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.179 | -5.52 | -2.83 | -4.42 | 6.05 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -13.5 | -17.2 | -17.5 | -16.9 | 0.525 |
| Capital Expenditures | -0.37 | -0.564 | -0.644 | -0.345 | -0.155 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.093 | -0.026 | 0.284 | -0.269 | 0.019 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.277 | -0.59 | -0.36 | -0.614 | -0.136 |
| Financing Cash Flow Items | 0 | — | 0.001 | -0.001 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.7 | 5.84 | 16.4 | 16.3 | 1.53 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15 | -11.9 | -1.45 | -1.2 | 1.92 |